Vistagen Therapeutics (VTGN): Kapitalizatsiya va daromad nisbati

VistaGen Therapeutics Inc (VTGN) brendining ramzi va logotipi

Sotuvlar nisbatidagi narx dinamikasi Vistagen Therapeutics (VTGN) daromadlarining bozor qiymatini aks ettiradi va hozirgi ko'rsatkich 3.50 darajasida turibdi. O'sish potentsiali xavotir buzilishlarini davolash uchun tez ta'sir qiluvchi spreylarning ishlab chiqilishiga asoslangan. Ilmiy tajribaga ega shaffof rahbariyat hozirda ishlab chiqish liniyasini qayta shakllantirmoqda, moliyaviy xarajatlarni minimallashtirish va yangi sinovlarni o'tkazish uchun strategik hamkorlarni jalb qilishga intilmoqda.

VTGN: Vistagen Therapeutics Kapitalizatsiyaning daromadga nisbati 04.07.2022 - 17.11.2026

Vistagen Therapeutics (VTGN) kompaniyasining tahliliy kesimlari

- joriy kotirovkalar va o'rtacha qiymat prognozi:
Kompaniyaning fundamental tahlili:VistaGen Therapeutics Inc, VTGN
VistaGen Therapeutics Inc tayyor mahsulotlari

P/S koeffitsiyenti bir dollarlik tushumning qiymatini belgilaydi va biznesning haqiqiy daromadidan yuqori bo'lgan bozor premiumini baholash imkonini beradi. Vistagen Therapeutics (VTGN) uchun ushbu koeffitsiyent klinikalarga burni orqali purkaydigan spreylarni birgalikda ishlab chiqishga oid kutishlarning kapitalizatsiyasini aks ettiradi. Tushum multiplikatorlari dinamikasini tahlil qilish orqali investor ilmiy yutuqlar fonida aktivning fundamental tendentsiyasi barqarorligini ko'rishi mumkin. Ko'rsatkichlarning me'yordagi qiymatlari kompaniyaning farmatsevtika salohiyati haddan tashqari yuqori baholanishi risklarini minimallashtiradi.

Raqobatdosh kompaniyalar

BIIB (Biogen) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NBIX (Neurocrine Corp)|Regencell Bioscience - Narxning daromadga nisbati|Axsome Therapeutics - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Pharmaceuticals)|Xenon (XENE) - Narxning daromadga nisbati|Sotuvga nisbatan narx Viking Therapeutics Inc (VKTX)|SUPN (Supernus Pharma) - P/S multiplikatori|CPRX: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori DNLI|Narx/daromad koeffitsiyenti Harmony Biosciences|Biohaven Ltd - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Amylyx Pharmaceuticals, Inc. AMLX|TRVI: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Praxis Corp PRAX|AVXL: P/S multiplikatori|CBLL (ceribell.com) - Narxning daromadga nisbati|PRTA (Prothena Corporation) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati alector.com (ALEC)|Narxning daromadga nisbati Annexon, Inc. (ANNX)|OMER - Sotuvga nisbatan narx|P/S multiplikatori NGNE (Neurogene Inc)|AC Immune (ACIU) - Sotuvga nisbatan narx|Voyager Therapeutics Inc - P/S multiplikatori|Neumora (NMRA) - Kapitalizatsiyaning daromadga nisbati|SCLX: P/S multiplikatori|TVGN - Narx/daromad koeffitsiyenti|ACOG (Alpha Cognition Inc) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati cogrx.com (CGTX)|Narxning daromadga nisbati Inhibikase Therapeutics Inc (IKT)|Narx/daromad koeffitsiyenti Cassava Sciences|P/S multiplikatori ASRT (Assertio Holdings)|COYA - Kapitalizatsiyaning daromadga nisbati|OVID: Kapitalizatsiyaning daromadga nisbati|ABOS: Narxning daromadga nisbati|CervoMed (CRVO) - Narxning daromadga nisbati|Sotuvga nisbatan narx Alterity Therapeutics Ltd (ATHE)|CLNN (Clene) - P/S multiplikatori|Kapitalizatsiya va daromad nisbati PEPG (PepGen)|Kapitalizatsiyaning daromadga nisbati JUNS (Jupiter Neurosciences, Inc.)|P/S multiplikatori relmada.com (RLMD)|Narxning daromadga nisbati Annovis Bio Corp ANVS|GRCE: Kapitalizatsiya va daromad nisbati|AIFF - Narxning daromadga nisbati|KLTO (anewmeds.com) - Kapitalizatsiya va daromad nisbati|NRSN (NeuroSense Therapeutics Ltd.) - Kapitalizatsiyaning daromadga nisbati|revivapharma.com - Bozor kapitallashuvining daromadga nisbati|MTVA (metaviatx.com) - P/S multiplikatori|NRXS: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori HSDT|PASG - Sotuvga nisbatan narx|P/S multiplikatori NEUP (Neuphoria Therapeutics)|NERV: Kapitalizatsiya va daromad nisbati|ATHA: Kapitalizatsiyaning daromadga nisbati|Addex Therapeutics Ltd - Kapitalizatsiyaning sotish hajmiga nisbati|Alzamend Neuro, Inc. (ALZN) - Narxning daromadga nisbati|CYCN (Cyclerion Therapeutics Inc.) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati PTIX|KTTA: Bozor kapitallashuvining daromadga nisbati|Kapitalizatsiyaning daromadga nisbati CRGT (Cortigent Medical)|ATXI (Avenue Therapeutics, Inc.) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Brainstorm Cell Therapeutics, Inc. BCLI|Bozor kapitallashuvining daromadga nisbati CARA|chromocell.com - P/S multiplikatori|Narxning sotuvga nisbati ELYM|ITCI: P/S multiplikatori|Sotuvga nisbatan narx Longboard Pharmaceuticals, Inc. (LBPH)|Narxning daromadga nisbati Marinus Pharmaceuticals, Inc.|NKGN: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NRBO|SAGE: Narxning sotuvga nisbati|Synaptogenix Inc. - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning sotish hajmiga nisbati TRVN (Trevena Inc.)|Vigil Neuroscience, Inc. - P/S multiplikatori|Anew Medical (WENA) - Kapitalizatsiyaning daromadga nisbati|CERE (Cerevel Corp) - Kapitalizatsiyaning daromadga nisbati